Immunocore Holdings PLC

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 447.06, 489.16, 582.87, 808.86, 1023.68 ], "ebit_estimate": [ -8.98, -22.04, -7.53, 211.89, 169.8 ], "ebitda_estimate": [ -6.08, -29.47, 20.15, 365.8, 538.4 ], "net_income_estimate": [ 6.99, -43.3, 4.44, 174.84, 159.73 ], "per_share_eps_estimate": [ 0.14, -0.28, 0.85, 3.82, 6.01 ], "eps_nri_estimate": [ 0.12, -0.45, 0.36, 3.82, 6.01 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 463.8, 522.81, 651.38, 9, 15.25 ], "pretax_income_estimate": [ 7.27, -9.8, 29.66, 239.36, 298.16 ], "operating_cash_flow_per_share_estimate": [ 1.02, 0.45, 1.77, 2.43, 6.11 ], "roa_estimate": [ 0.5, -6.1, -0.5, 9.8, 25.3 ], "roe_estimate": [ 8.01, 6.15, 14.06, 27.5, 49.9 ], "gross_margin_estimate": [ 99.06, 98.68, 96.4, 93, 93.5 ], "operating_cash_flow_estimate": [ 54.15, 23.98, 93.75, 128.63, 323.43 ], "pettm_estimate": [ 228.21, 0, 37.5, 8.37, 5.31 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "12.97", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 12.97, "future_ebit_estimate_growth": 36.16, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 285.96, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -0.75, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 110.34, 113.68, 116.67, 120.78, 124.51, 127.78, 131.63 ], "ebit_estimate": [ -2.78, -4.41, -10.18, -8.81, -9.06, -11.12, -13.56 ], "ebitda_estimate": [ -6.56, -5.09, -8.92, null, null, null, null ], "net_income_estimate": [ 1.15, -0.7, -5.43, -4.31, -4.49, -6.14, -8.07 ], "per_share_eps_estimate": [ 0.02, -0.02, -0.11, -0.06, -0.03, 0.02, 0.08 ], "eps_nri_estimate": [ 0.01, -0.01, -0.12, -0.03, -0.01, 0.05, 0.09 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ 2.06, 0.03, -5.11, -4.31, -4.49, -6.14, -8.07 ], "operating_cash_flow_per_share_estimate": [ 0.18, 0.22, 0.27, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 99, 99, 98.5, 99, 99, 99, 99 ], "operating_cash_flow_estimate": [ 9.42, 11.7, 14.08, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "12.97", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 12.97, "future_ebit_estimate_growth": 36.16, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 285.96, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -0.75, "future_operating_cash_flow_per_share_estimate_growth": null }